Sir Ratan Tata Trust

Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors

Retrieved on: 
Tuesday, February 13, 2024
Therapy, School, Sir Ratan Tata Trust, Cadila Pharmaceuticals, Entrepreneurship, AI, Investment, Growth, Silicon, Senior advisor, AACR, Roche, Lead, Partner, Leber's hereditary optic neuropathy, Trustee, Patient, SIX Swiss Exchange, Knowledge, Max Healthcare, Stanford University, Pharmaceutical industry

“We are thrilled to announce the addition of Dr. Singh and Dr. Meier to the Board of Directors of Onconetix,” stated Chairman of the Board James Sapirstein.

Key Points: 
  • “We are thrilled to announce the addition of Dr. Singh and Dr. Meier to the Board of Directors of Onconetix,” stated Chairman of the Board James Sapirstein.
  • Dr. Singh serves as an Adjunct Professor in the School of Medicine at Stanford, where he teaches clinical diagnostics and entrepreneurship.
  • Dr. Singh has held several board positions including Lead Director at Max Healthcare, board member at Cadila Pharmaceuticals, and Senior Advisor to the Tata Trusts Cancer program.
  • He is co-founder, board member and advisor for several biotech companies in Switzerland and the US.

Chronus Health Appoints Dr. Ajit Singh as Chairman of the Board of Directors

Retrieved on: 
Thursday, June 8, 2023
Columbia University, Conditional sentence, Bachelor, Executive, AACR, Max Healthcare, The Washington Campus Board of Directors, Senior advisor, Roche, COVID-19, Cancer, Ageing, Stanford University, COVID-19 testing, Computer, Sir Ratan Tata Trust, Organization, Silicon, Syracuse University, Book, Entrepreneurship, Partner, Trustee, School, Master, Knowledge, Computer science, Banaras Hindu University, Electricity, Virginia Tech Carilion School of Medicine and Research Institute, Medical device, Management, Medicine

FREMONT, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- Chronus Health, Inc. , a disruptor in point-of-care diagnostics, today announced it has appointed Dr. Ajit Singh as Chairman of the company's Board of Directors.

Key Points: 
  • FREMONT, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- Chronus Health, Inc. , a disruptor in point-of-care diagnostics, today announced it has appointed Dr. Ajit Singh as Chairman of the company's Board of Directors.
  • Dr. Singh is currently a Partner at Artiman Ventures, a Silicon Valley-based venture capital firm, serving on the Board of Directors of several life sciences and healthcare portfolio companies.
  • He is also an Adjunct Professor in the School of Medicine at Stanford, where he teaches diagnostics and entrepreneurship.
  • In addition, he is a member of the Board of Trustees of the American Association for Cancer Research (AACR) Foundation.

Entrepreneurship and urban research the focus of new centre launched in Mumbai by University of Toronto with Tata Trusts

Retrieved on: 
Wednesday, February 1, 2023
Toronto Centre, University of Toronto, Entrepreneurship, U of T, Sir Ratan Tata Trust, Poverty, Water, Partnership, University, Mail order, Creative industries, Pharmaceutical industry

Toronto, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The University of Toronto launched The University of Toronto Centre in India today in Mumbai in partnership with Tata Trusts, one of India’s largest philanthropic organizations.

Key Points: 
  • Toronto, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The University of Toronto launched The University of Toronto Centre in India today in Mumbai in partnership with Tata Trusts, one of India’s largest philanthropic organizations.
  • Tata Trusts has been a longstanding collaborator with U of T, supporting researchers across the university to address health care, water, energy and poverty challenges.
  • The new centre will give focus to this collaboration with an emphasis on urban research and entrepreneurship, bringing together leading scholars and innovators from Canada and India to develop ground-breaking research and innovation to benefit people in India and around the world.

Entrepreneurship and urban research the focus of new centre launched in Mumbai by University of Toronto with Tata Trusts

Retrieved on: 
Wednesday, February 1, 2023
Toronto Centre, University of Toronto, Entrepreneurship, U of T, Sir Ratan Tata Trust, Poverty, Toronto, Water, Partnership, University, Film, Creative industries, Clothing

Mumbai, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The University of Toronto launched The University of Toronto Centre in India today in Mumbai in partnership with Tata Trusts, one of India’s largest philanthropic organizations.

Key Points: 
  • Mumbai, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The University of Toronto launched The University of Toronto Centre in India today in Mumbai in partnership with Tata Trusts, one of India’s largest philanthropic organizations.
  • Tata Trusts has been a longstanding collaborator with U of T, supporting researchers across the university to address health care, water, energy and poverty challenges.
  • The new centre will give focus to this collaboration with an emphasis on urban research and entrepreneurship, bringing together leading scholars and innovators from Canada and India to develop ground-breaking research and innovation to benefit people in India and around the world.

Neurotechnology Announces MOSIP Integration and Support in MegaMatcher SDK and ABIS

Retrieved on: 
Wednesday, June 15, 2022
MacOS, Privacy, Microsoft Windows, Bill, Android, Aadhaar, Technology, Robotics, Iris, Human, Artificial intelligence, ARM, International Institute of Information Technology, Hyderabad, Business, NIST, Sir Ratan Tata Trust, API, Algorithm, Information technology, ABIS, IOS, Omidyar Network, Ecosystem, Software, Law enforcement, ID, Linux, Microsoft, FRVT, Neurotechnology, Multimedia, PFT, SDK, IREX, Face, Organization, Cryptocurrency, Security printing, North American Aerospace Defense Command, Head

VILNIUS, Lithuania, June 15, 2022 /PRNewswire/ -- Neurotechnology, a provider of deep learning-based solutions and high-precision biometric identification technologies, today announced the integration and support of the Modular Open Source Identity Platform (MOSIP) for its MegaMatcher ABIS and MegaMatcher SDK products. MOSIP is a modular and open source identity platform that helps user organizations, such as governments, implement a digital, foundational identification (ID) system in a cost effective way. ID systems are the backbone for effective delivery of public and private services worldwide, and Neurotechnology's MegaMatcher ABIS and MegaMatcher SDK multi-biometric identification systems deliver on MOSIP best practices for scalability, security and privacy.

Key Points: 
  • ID systems arethe backbone for effective delivery of public and private services worldwide, and Neurotechnology's MegaMatcher ABIS and MegaMatcher SDK multi-biometric identification systems deliver onMOSIP best practices for scalability, security and privacy.
  • MegaMatcher SDK and MegaMatcher ABIS can now be used in existing and future MOSIP-based large-scale identity projects.
  • MegaMatcher SDK is a comprehensive development kit used to create and realize single- or multi-biometric applications and systems for Microsoft Windows, Linux, macOS, iOS, Android and ARM Linux platforms.
  • The MOSIP implementation of MegaMatcher ABIS is also available through the MOSIP Market Place, recently announced by MOSIP during ID4Africa 2022 event in Morocco.

SpinaFX Medical to Exhibit at Society of Interventional Radiology Annual Scientific Meeting

Retrieved on: 
Friday, June 10, 2022
Interventional radiology, Society of Interventional Radiology, Sir Ratan Tata Trust, Goal, Research, Spine, The Spine Journal, Forward-looking statement, Radiculopathy, News, Society, Back pain, Multimedia, SIR, Patient, DRS, Technology, Abstract (summary), Medical device, Medical imaging, Risk management

TORONTO, June 10, 2022 /PRNewswire/ - Minimally invasive image-guided therapy company, SpinaFX Medical Inc. (SpinaFX), today announced it will exhibit at the Society of Interventional Radiology (SIR) 2022 Annual Scientific Meeting in Boston, MA, June 11-16, at booth 414.

Key Points: 
  • TORONTO, June 10, 2022 /PRNewswire/ - Minimally invasive image-guided therapy company, SpinaFX Medical Inc. (SpinaFX), today announced it will exhibit at the Society of Interventional Radiology (SIR) 2022 Annual Scientific Meeting in Boston, MA, June 11-16, at booth 414.
  • "We are excited to meet with some of the world's leading interventional radiologists to discuss innovations in minimally invasive, image-guided care and share our recent progress and momentum at SpinaFX," said Jeff Cambra, SpinaFX CEO.
  • "I am thrilled that Dr. Kelekis will share the findings of our skilled research team at SIR's Annual Scientific Meeting," said Dr. Kieran Murphy, SpinaFX Chief Medical Officer and co-author of the recognized study.
  • As an exhibitor during the meeting on June 11-16, SpinaFX will offer attendees the opportunity to discuss the study results and their implications with Drs.

Global Radiation Oncology Market Analysis Report 2021-2028: Focus on External Beam Radiation Therapy & Internal Beam Radiation Therapy - ResearchAndMarkets.com

Retrieved on: 
Monday, October 18, 2021
Radiology, Health, Oncology, Ethos, Incidence, Varian Medical Systems, Industry, Lists of countries and territories, CAGR, Cancer, Growth, Radiation, Population, Radiation therapy, Knowledge, USD, Technology, FDA, Cobalt therapy, Brachytherapy, Elekta, EBRT, Application, Sir Ratan Tata Trust, Prostate cancer, Memorandum of understanding, Medical imaging, Medical device

The "Global Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), by Application, by Technology, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Radiation Oncology Market Size, Share & Trends Analysis Report by Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), by Application, by Technology, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global radiation oncology market size is expected to reach USD 11.7 billion by 2028, registering a CAGR of 7.0%
    The rising incidence of cancer and technological advancement in radiation therapy equipment are some of the major factors driving the growth of the market.
  • There have been various technological advancements in radiotherapy equipment over the last decade, which has been a major factor for growth.
  • Advancement from 2D to 3D conformal radiotherapy, motion tracking, and real-time imaging has helped improve radiation targeting and thereby reduce exposure to the surrounding healthy tissues.